DexCom

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade DexCom 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DXCM

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. 

CEO
Jacob S. Leach
CEOJacob S. Leach
Employees
11,100
Employees11,100
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1999
Founded1999
Employees
11,100
Employees11,100

DXCM Key Statistics

Market cap
28.60B
Market cap28.60B
Price-Earnings ratio
32.65
Price-Earnings ratio32.65
Dividend yield
Dividend yield
Average volume
4.35M
Average volume4.35M
High today
High today
Low today
Low today
Open price
$75.09
Open price$75.09
Volume
101.00
Volume101.00
52 Week high
$89.98
52 Week high$89.98
52 Week low
$54.11
52 Week low$54.11

Stock Snapshot

With a market cap of 28.6B, DexCom(DXCM) trades at $74.12. The stock has a price-to-earnings ratio of 32.65.

On 2026-07-15, DexCom(DXCM) stock opened at $75.09, reached a high of —, and a low of —.

DexCom(DXCM) shares are trading with a volume of 101, against a daily average of 4.35M.

During the past year, DexCom(DXCM) stock moved between $54.11 at its lowest and $89.98 at its peak.

During the past year, DexCom(DXCM) stock moved between $54.11 at its lowest and $89.98 at its peak.

DXCM News

TipRanks 2h
DexCom price target raised to $90 from $85 at Mizuho

Mizuho raised the firm’s price target on DexCom (DXCM) to $90 from $85 and keeps an Outperform rating on the shares. The firm adjusted targets in the medical de...

MarketWatch 16h
DexCom Inc. stock outperforms competitors despite losses on the day - MarketWatch

...

DexCom Inc. stock outperforms competitors despite losses on the day - MarketWatch
Simply Wall St 4d
DexCom Could Be 10% Overvalued As Recall Adds Fresh Questions

DexCom (DXCM) has drawn fresh attention after voluntarily initiating a Class II recall of certain Dexcom G7 sensor lots that were stolen during the destruction...

DexCom Could Be 10% Overvalued As Recall Adds Fresh Questions

Analyst ratings

84%

of 31 ratings
Buy
83.9%
Hold
16.1%
Sell
0%

People also own

Based on the portfolios of people who own DXCM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.